Efficacy and Safety of a Subcutaneous Tanezumab Titration Dosing Regimen in Subjects With Moderate to Severe Osteoarthritis of the Hip or Knee
A Phase 3 Randomized, Double-Blind, Placebo Multicenter Study of the Analgesic Efficacy and Safety of A
Dose Titration Regimen for the Subcutaneous Administration of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee
Category & Conditions: Immune System Diseases and Conditions
Medicine: tanezumab
ClinicalTrials.gov Identifier (NCT): NCT02697773
Protocol ID: A4091056
PrintDownloadOpen Plain Language Summary Result: Click here